Inventor · San Francisco, CA, US

Uma Sinha

33Patents
12h-index
18Co-inventors
78Inventor score

Filing activity: Jun 29, 1994 → Jun 29, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5721214A Inhibitors of factor Xa Human Necessities 37 Expired
US5583107A Agents affecting thrombosis and hemostasis Emerging Cross-Sectional Technologies 30 Expired
US8153590B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 27 Active
US8268783B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 25 Active
US8455439B2 Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents Human Necessities 22 Active
US5837679A Agents affecting thrombosis and hemostasis Emerging Cross-Sectional Technologies 22 Expired
US10004725B2 Methods of treatment Chemistry; Metallurgy 17 Active
US8455441B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 17 Active
US6245743A Inhibitors of factor Xa Human Necessities 17 Expired
US5990079A Agents affecting thrombosis and hemostasis Emerging Cross-Sectional Technologies 13 Expired
US9056106B2 Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same Chemistry; Metallurgy 13 Active
US9109046B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 12 Active
US9388401B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 12 Active
US9062298B2 Antidotes for factor XA inhibitors and methods of using the same Human Necessities 12 Active
US8889129B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 11 Active
US9587233B2 Antidotes for factor XA inhibitors and methods of using the same Human Necessities 8 Active
US8404724B2 Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor Human Necessities 6 Active
US11058668B2 Methods of treating TTR amyloidosis using AG10 Human Necessities 4 Active
US5798332A Glycosylation-mediated inhibition of factor X Emerging Cross-Sectional Technologies 3 Expired
US5968897A Agents affecting thrombosis and hemostasis Emerging Cross-Sectional Technologies 2 Expired
US8455440B2 Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor Human Necessities 2 Active
US10954503B2 Antidotes for factor Xa inhibitors and methods of using the same Human Necessities 1 Active
US5919765A Inhibitors of factor XA Human Necessities 1 Expired
US8946219B2 Combination therapy with a compound acting as a platelet ADP receptor inhibitor Human Necessities 1 Active
US6117836A Glycosylation-mediated inhibition of factor X Emerging Cross-Sectional Technologies 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.